The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
B-cell acute lymphoblastic leukemia (B-ALL) in CLL patients treated with lenalidomide.
 
Moritz Fuerstenau
No Relationships to Disclose
 
Anna-Maria Fink
Research Funding - Celgene (Inst)
Travel, Accommodations, Expenses - Abbvie
 
Carmen Herling
Research Funding - Roche
 
Christian Maurer
Travel, Accommodations, Expenses - Amgen; Mundipharma
 
Nadine Kutsch
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Abbvie
 
Javier De La Serna
No Relationships to Disclose
 
Marta Coscia
Honoraria - Abbvie; Gilead Sciences; Janssen
Consulting or Advisory Role - Abbvie; Gilead Sciences; Shire
Research Funding - Janssen; Karyopharm Therapeutics
Travel, Accommodations, Expenses - Gilead Sciences; Roche
 
Marta Crespo
Research Funding - Janssen
Travel, Accommodations, Expenses - Genentech
 
Francesc Bosch
Honoraria - Celgene; Roche
Consulting or Advisory Role - Celgene; Roche
Research Funding - Celgene; Roche
 
Thomas Noesslinger
No Relationships to Disclose
 
Paolo Ghia
Honoraria - Abbvie; Acerta Pharma; BeiGene; Gilead Sciences; Janssen
Consulting or Advisory Role - Abbvie; Acerta Pharma; BeiGene; Gilead Sciences; Janssen
Speakers' Bureau - Gilead Sciences
Research Funding - Abbvie; Acerta Pharma; BeiGene; Gilead Sciences; Janssen; Novartis
 
Arnon P. Kater
Consulting or Advisory Role - Abbvie; Janssen; Sunesis Pharmaceuticals
Research Funding - Abbvie; Acerta Pharma; AstraZeneca; Celgene; Genentech/Roche; Janssen
 
Matthias Ritgen
No Relationships to Disclose
 
Anke Schilhabel
No Relationships to Disclose
 
Stephan Stilgenbauer
Honoraria - Abbvie; Amgen; AstraZeneca; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen; Novartis; Roche
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen; Novartis; Roche
Speakers' Bureau - Abbvie; Amgen; AstraZeneca; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen; Novartis; Roche
Research Funding - Abbvie; Amgen; AstraZeneca; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen; Novartis; Roche
Travel, Accommodations, Expenses - Abbvie; Amgen; AstraZeneca; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen; Novartis; Roche
 
Eugen Tausch
Honoraria - Gilead Sciences
Research Funding - Novartis
Travel, Accommodations, Expenses - Amgen; Celgene; Gilead Sciences; GlaxoSmithKline
 
Kirsten Fischer
Travel, Accommodations, Expenses - Roche
 
Michael J. Hallek
Honoraria - Abbvie; Gilead Sciences; Janssen; Roche
Consulting or Advisory Role - Abbvie; Gilead Sciences; Janssen; Roche
Speakers' Bureau - Abbvie; Gilead Sciences; Janssen; Roche
Research Funding - Abbvie; Gilead Sciences; Janssen; Roche
Travel, Accommodations, Expenses - Janssen; Roche
 
Barbara Eichhorst
Consulting or Advisory Role - Abbvie; Gilead Sciences; Janssen-Cilag; Novartis; Roche
Speakers' Bureau - Abbvie; Celgene; Gilead Sciences; Janssen-Cilag; Roche/Genentech
Research Funding - Abbvie; Gilead Sciences; Janssen; Roche
Travel, Accommodations, Expenses - GlaxoSmithKline; Mundipharma; Roche